NO20032292L - Anvendelse av Rosuvastatin (ZD-4522) ved behandling av heterozygot famili¶rhyperkolesterolemi - Google Patents

Anvendelse av Rosuvastatin (ZD-4522) ved behandling av heterozygot famili¶rhyperkolesterolemi

Info

Publication number: NO20032292L
Authority: NO; Norway
Prior art keywords: rosuvastatin; treatment; heterozygous familial; familial hypercholesterolaemia; hypercholesterolaemia
Prior art date: 2000-11-22

Application number

NO20032292A

Other languages

English (en)

Other versions

NO326245B1 (no

NO20032292D0 (no

Inventor

Ali Raza

Howard Gerard Hutchinson

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-11-22

Filing date

2003-05-21

Publication date

2003-07-17

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9903629&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20032292(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2003-05-21 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2003-05-21 Publication of NO20032292D0 publication Critical patent/NO20032292D0/no

2003-07-17 Publication of NO20032292L publication Critical patent/NO20032292L/no

2008-10-27 Publication of NO326245B1 publication Critical patent/NO326245B1/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Diabetes (AREA)
Hematology (AREA)
Epidemiology (AREA)
Obesity (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Endocrinology (AREA)
Emergency Medicine (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

NO20032292A 2000-11-22 2003-05-21 Anvendelse av et statin for fremstilling av et medikament ved behandling av heterozygot familiaer hyperkolesterolemi NO326245B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0028429.9A GB0028429D0 (en)	2000-11-22	2000-11-22	Therapy
PCT/GB2001/005041 WO2002041895A1 (en)	2000-11-22	2001-11-16	Use of rosuvastatin (zd-4522) in the treatment of heterozygous familial hypercholesterolemia

Publications (3)

Publication Number	Publication Date
NO20032292D0 NO20032292D0 (no)	2003-05-21
NO20032292L true NO20032292L (no)	2003-07-17
NO326245B1 NO326245B1 (no)	2008-10-27

Family

ID=9903629

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20032292A NO326245B1 (no)	2000-11-22	2003-05-21	Anvendelse av et statin for fremstilling av et medikament ved behandling av heterozygot familiaer hyperkolesterolemi

Country Status (35)

Country	Link
US (1)	US6858618B2 (no)
EP (1)	EP1339409B1 (no)
JP (2)	JP5062940B2 (no)
KR (1)	KR100815042B1 (no)
CN (1)	CN1268339C (no)
AR (1)	AR031766A1 (no)
AT (1)	ATE394103T1 (no)
AU (2)	AU2002214165B9 (no)
BG (1)	BG66009B1 (no)
BR (1)	BR0115511A (no)
CA (1)	CA2429263C (no)
CY (1)	CY1110428T1 (no)
CZ (1)	CZ301583B6 (no)
DE (1)	DE60133921D1 (no)
DK (1)	DK1339409T3 (no)
EE (1)	EE05507B1 (no)
ES (1)	ES2305118T3 (no)
GB (1)	GB0028429D0 (no)
HK (1)	HK1056691A1 (no)
HU (1)	HUP0301380A3 (no)
IL (2)	IL155919A0 (no)
IS (1)	IS6819A (no)
MX (1)	MXPA03004336A (no)
MY (1)	MY134902A (no)
NO (1)	NO326245B1 (no)
NZ (1)	NZ525754A (no)
PL (1)	PL365386A1 (no)
PT (1)	PT1339409E (no)
RU (1)	RU2294744C2 (no)
SI (1)	SI1339409T1 (no)
SK (1)	SK6212003A3 (no)
TW (1)	TWI238720B (no)
UA (1)	UA75614C2 (no)
WO (1)	WO2002041895A1 (no)
ZA (1)	ZA200303636B (no)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0003305D0 (en)	2000-02-15	2000-04-05	Zeneca Ltd	Pyrimidine derivatives
US7407965B2 (en) *	2003-04-25	2008-08-05	Gilead Sciences, Inc.	Phosphonate analogs for treating metabolic diseases
US7452901B2 (en) *	2003-04-25	2008-11-18	Gilead Sciences, Inc.	Anti-cancer phosphonate analogs
PT1628685E (pt)	2003-04-25	2011-03-16	Gilead Sciences Inc	Análogos de fosfonatos antivirais
US7470724B2 (en) *	2003-04-25	2008-12-30	Gilead Sciences, Inc.	Phosphonate compounds having immuno-modulatory activity
US20090247488A1 (en) *	2003-04-25	2009-10-01	Carina Cannizzaro	Anti-inflammatory phosphonate compounds
US20050261237A1 (en) *	2003-04-25	2005-11-24	Boojamra Constantine G	Nucleoside phosphonate analogs
AU2004233897A1 (en) *	2003-04-25	2004-11-11	Gilead Sciences, Inc.	Kinase inhibitor phosphonate conjugates
CA2657076A1 (en) *	2003-08-28	2005-03-17	Teva Pharmaceutical Industries Ltd.	Process for the preparation of rosuvastatin calcium
GB0322552D0 (en)	2003-09-26	2003-10-29	Astrazeneca Uk Ltd	Therapeutic treatment
US7432273B2 (en) *	2003-10-24	2008-10-07	Gilead Sciences, Inc.	Phosphonate analogs of antimetabolites
US7777034B2 (en)	2003-11-24	2010-08-17	Teva Pharmaceutical Industries Ltd.	Crystalline ammonium salts of rosuvastatin
CN1894221B (zh) *	2003-12-02	2012-08-08	特瓦制药工业有限公司	用于表征罗苏伐他汀的参照标准品
US7851624B2 (en) *	2003-12-24	2010-12-14	Teva Pharamaceutical Industries Ltd.	Triol form of rosuvastatin and synthesis of rosuvastatin
US20070179166A1 (en) *	2003-12-24	2007-08-02	Valerie Niddam-Hildesheim	Process for preparation of statins with high syn to anti ratio
WO2005115377A1 (en) *	2004-05-26	2005-12-08	Kgk Synergize Inc	Functional foods comprising flavonoids and tocotrienols and methods thereof
CA2573857A1 (en) *	2004-07-13	2006-02-16	Teva Pharmaceutical Industries Ltd.	A process for the preparation of rosuvastatin involving a tempo-mediated oxidation step
PL216369B1 (pl)	2004-07-27	2014-03-31	Gilead Sciences	Pochodne fosfonianowe, kompozycje farmaceutyczne zawierające te pochodne oraz zastosowanie tych pochodnych do wytwarzania leku do hamowania wirusa HIV
US7612203B2 (en)	2005-02-22	2009-11-03	Teva Pharmaceutical Industries Ltd.	Rosuvastatin and salts thereof free of rosuvastatin alkylether and a process for the preparation thereof
US20070037979A1 (en) *	2005-02-22	2007-02-15	Valerie Niddam-Hildesheim	Preparation of rosuvastatin
US20070167625A1 (en) *	2005-02-22	2007-07-19	Anna Balanov	Preparation of rosuvastatin
US7868169B2 (en) *	2005-08-16	2011-01-11	Teva Pharmaceutical Industries, Ltd.	Crystalline rosuvastatin intermediate
US8383614B2 (en) *	2008-01-31	2013-02-26	The Trustees Of The University Of Pennsylvania	Hypercholestrolemia and tendinous injuries
US9427437B2 (en)	2008-01-31	2016-08-30	The Trustees Of The University Of Pennsylvania	Hypercholesterolemia and tendinous injuries
CA2725052C (en)	2008-05-27	2014-09-16	Changzhou Pharmaceutical Factory Co., Ltd.	Preparation method of rosuvastatin calcium and its intermediates
DK2307435T3 (da)	2008-07-08	2012-09-10	Gilead Sciences Inc	Salte af HIV-inhibitorforbindelser
EP4023641B1 (en)	2012-09-17	2024-05-01	Madrigal Pharmaceuticals, Inc.	Method of synthesizing thyroid hormone analogs and polymorphs thereof
US9132117B2 (en)	2013-06-17	2015-09-15	Kgk Synergize, Inc	Compositions and methods for glycemic control of subjects with impaired fasting glucose
US10600502B2 (en)	2016-12-20	2020-03-24	Astrazeneca Uk Ltd.	Systems and methods for dispensing a statin medication over the counter
ES2892402T3 (es)	2017-08-01	2022-02-04	Gilead Sciences Inc	Formas cristalinas de ((S)-((((2R,5R)-5-(6-amino-9H-purin-9-il)-4-fluoro-2,5-dihidrofuran-2-il)oxi)metil)(fenoxi)fosforil)-L-alaninato de etilo para tratar infecciones virales
CA3141505A1 (en)	2019-05-27	2020-12-03	Immatics US, Inc.	Viral vectors and their use in adoptive cellular therapy
DE102020111571A1 (de)	2020-03-11	2021-09-16	Immatics US, Inc.	Wpre-mutantenkonstrukte, zusammensetzungen und zugehörige verfahren
US20220008519A1 (en)	2020-07-09	2022-01-13	Costa Rican Social Security Fund / Caja Costarricense de Seguro Social (CCSS)	Treatment of severe acute respiratory syndrome-related coronavirus infection with klotho
US20220056411A1 (en)	2020-08-21	2022-02-24	Immatics US, Inc.	Methods for isolating cd8+ selected t cells
AU2022213405A1 (en) *	2021-02-01	2023-08-03	Madrigal Pharmaceuticals, Inc.	Therapeutic combinations of rosuvastatin and resmetirom for the treatment of liver disorders or lipid disorders

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2648897B2 (ja) *	1991-07-01	1997-09-03	塩野義製薬株式会社	ピリミジン誘導体
US6369103B1 (en) *	1994-01-18	2002-04-09	Bristol-Myers Squibb Company	Method for preventing or reducing risk of onset of cardiovascular events employing an HMG CoA reductase inhibitor
GB0001621D0 (en) *	2000-01-26	2000-03-15	Astrazeneca Ab	Pharmaceutical compositions
TWI293877B (en) *	2000-09-20	2008-03-01	Rtp Pharma Inc	Spray drying process and compositions of fenofibrate

2000
- 2000-11-22 GB GBGB0028429.9A patent/GB0028429D0/en not_active Ceased
2001
- 2001-11-16 DE DE60133921T patent/DE60133921D1/de not_active Expired - Lifetime
- 2001-11-16 PL PL01365386A patent/PL365386A1/xx not_active Application Discontinuation
- 2001-11-16 MX MXPA03004336A patent/MXPA03004336A/es unknown
- 2001-11-16 AU AU2002214165A patent/AU2002214165B9/en not_active Revoked
- 2001-11-16 SK SK621-2003A patent/SK6212003A3/sk not_active Application Discontinuation
- 2001-11-16 AU AU1416502A patent/AU1416502A/xx active Pending
- 2001-11-16 PT PT01982623T patent/PT1339409E/pt unknown
- 2001-11-16 CZ CZ20031406A patent/CZ301583B6/cs not_active IP Right Cessation
- 2001-11-16 SI SI200130839T patent/SI1339409T1/sl unknown
- 2001-11-16 KR KR1020037006791A patent/KR100815042B1/ko not_active Ceased
- 2001-11-16 CA CA002429263A patent/CA2429263C/en not_active Expired - Fee Related
- 2001-11-16 EE EEP200300239A patent/EE05507B1/xx not_active IP Right Cessation
- 2001-11-16 AT AT01982623T patent/ATE394103T1/de active
- 2001-11-16 IL IL15591901A patent/IL155919A0/xx unknown
- 2001-11-16 UA UA2003054394A patent/UA75614C2/uk unknown
- 2001-11-16 NZ NZ525754A patent/NZ525754A/en not_active IP Right Cessation
- 2001-11-16 US US10/432,402 patent/US6858618B2/en not_active Expired - Lifetime
- 2001-11-16 WO PCT/GB2001/005041 patent/WO2002041895A1/en active IP Right Grant
- 2001-11-16 CN CNB018221599A patent/CN1268339C/zh not_active Expired - Lifetime
- 2001-11-16 DK DK01982623T patent/DK1339409T3/da active
- 2001-11-16 JP JP2002544073A patent/JP5062940B2/ja not_active Expired - Lifetime
- 2001-11-16 RU RU2003114300/15A patent/RU2294744C2/ru not_active IP Right Cessation
- 2001-11-16 BR BR0115511-3A patent/BR0115511A/pt not_active Application Discontinuation
- 2001-11-16 EP EP01982623A patent/EP1339409B1/en not_active Revoked
- 2001-11-16 HU HU0301380A patent/HUP0301380A3/hu not_active Application Discontinuation
- 2001-11-16 ES ES01982623T patent/ES2305118T3/es not_active Expired - Lifetime
- 2001-11-20 MY MYPI20015303A patent/MY134902A/en unknown
- 2001-11-21 TW TW090128858A patent/TWI238720B/zh not_active IP Right Cessation
- 2001-11-22 AR ARP010105452A patent/AR031766A1/es unknown
2003
- 2003-05-12 ZA ZA200303636A patent/ZA200303636B/en unknown
- 2003-05-13 BG BG107811A patent/BG66009B1/bg unknown
- 2003-05-14 IL IL155919A patent/IL155919A/en unknown
- 2003-05-19 IS IS6819A patent/IS6819A/is unknown
- 2003-05-21 NO NO20032292A patent/NO326245B1/no not_active IP Right Cessation
- 2003-12-16 HK HK03109170A patent/HK1056691A1/xx not_active IP Right Cessation
2008
- 2008-07-07 CY CY20081100703T patent/CY1110428T1/el unknown
2009
- 2009-11-09 JP JP2009255813A patent/JP2010031047A/ja active Pending

Also Published As

Publication number	Publication date
TWI238720B (en)	2005-09-01
IL155919A0 (en)	2003-12-23
NO326245B1 (no)	2008-10-27
CA2429263A1 (en)	2002-05-30
US20040072852A1 (en)	2004-04-15
UA75614C2 (uk)	2006-05-15
EE05507B1 (et)	2012-02-15
JP5062940B2 (ja)	2012-10-31
BR0115511A (pt)	2003-12-30
CY1110428T1 (el)	2015-04-29
DK1339409T3 (da)	2008-09-08
AU1416502A (en)	2002-06-03
CA2429263C (en)	2009-03-17
CZ20031406A3 (cs)	2003-09-17
ATE394103T1 (de)	2008-05-15
HUP0301380A2 (hu)	2003-10-28
BG66009B1 (bg)	2010-10-29
RU2294744C2 (ru)	2007-03-10
PT1339409E (pt)	2008-07-07
SI1339409T1 (sl)	2008-08-31
WO2002041895A1 (en)	2002-05-30
CZ301583B6 (cs)	2010-04-21
KR20030048479A (ko)	2003-06-19
IL155919A (en)	2009-09-01
JP2004522714A (ja)	2004-07-29
HUP0301380A3 (en)	2007-03-28
AU2002214165B9 (en)	2013-07-04
IS6819A (is)	2003-05-19
MY134902A (en)	2007-12-31
EP1339409B1 (en)	2008-05-07
CN1268339C (zh)	2006-08-09
NZ525754A (en)	2004-10-29
KR100815042B1 (ko)	2008-03-18
GB0028429D0 (en)	2001-01-10
US6858618B2 (en)	2005-02-22
HK1056691A1 (en)	2004-02-27
AR031766A1 (es)	2003-10-01
BG107811A (bg)	2004-03-31
JP2010031047A (ja)	2010-02-12
CN1630520A (zh)	2005-06-22
PL365386A1 (en)	2005-01-10
EP1339409A1 (en)	2003-09-03
ZA200303636B (en)	2004-08-12
SK6212003A3 (en)	2003-11-04
AU2002214165B2 (en)	2006-12-14
ES2305118T3 (es)	2008-11-01
EE200300239A (et)	2003-08-15
DE60133921D1 (de)	2008-06-19
NO20032292D0 (no)	2003-05-21
MXPA03004336A (es)	2003-08-19

Publication	Publication Date	Title
NO20032292D0 (no)	2003-05-21	Anvendelse av Rosuvastatin (ZD-4522) ved behandling av heterozygot famili¶rhyperkolesterolemi
NO20034166L (no)	2003-11-20	Molekyl¶re konjugater for anvendelse ved behandling av cancer
NO20015046L (no)	2002-04-19	Integrert pumpeutstyr for bruk ved pumping av flere forskjellige fluider
DE60043067D1 (de)	2009-11-12	Quadrupol-ionenfalle und zugehöriges verwendungsverfahren
NO20031193D0 (no)	2003-03-14	B¶rbar hårtörrer
NO20042710L (no)	2004-08-30	Dosimeterlapp til engangsbruk til bruk ved straleterapi
NO20026008D0 (no)	2002-12-13	Fremgangsmåte for behandling av cardiovaskul¶re sykdommer
NO20021964D0 (no)	2002-04-25	Biologisk fluidbehandling
EE200300473A (et)	2004-02-16	Tsüano-asendatud dihüdropürimidiinühendid ja nende kasutamine haiguste raviks
IS6967A (is)	2003-09-24	Ný cýanó-tengd díhýdrópýrimídín efnasambönd og notkun þeirra við meðhöndlun sjúkdóma
DE69921915D1 (de)	2004-12-23	Photokatalytische Anregungsvorrichtung
DK1404312T3 (da)	2011-03-14	Carbamatforbindelser til anvendelse ved smertebehandling
NO20035501D0 (no)	2003-12-10	Vaskev¶skefordelingssystem
DE10085461T1 (de)	2003-11-13	Chirurgische Zugangsvorrichtung
AU2002248723A8 (en)	2006-12-07	Molecules for disease detection and treatment
EP1390410A4 (en)	2006-01-11	MOLECULES FOR THE DETECTION AND TREATMENT OF DISEASES
NO20042166L (no)	2004-05-25	Kombinasjonsterapi for behandling av sykdom
EP1552845A4 (en)	2006-06-07	MEANS FOR THE PREVENTION / TREATMENT OF CANCER
NO20014247L (no)	2003-03-03	Anordning ved törrklosett/biologisk toalett
IT1310450B1 (it)	2002-02-13	Dispositivo per il lavaggio di strumenti e/o accessori ambulatoriali.
DE69933934D1 (de)	2006-12-21	Handbrause und Filtergehäuse
NO20015343D0 (no)	2001-11-01	Skj¶reventil
NO20015053D0 (no)	2001-10-17	Oppl¶ringssett
NO20014710D0 (no)	2001-09-28	Utaskj¶rsheis
FIU20000507U0 (fi)	2000-12-22	Clinikit DiagnoPacks ja Openkit-konsepti

Legal Events

Date	Code	Title	Description
2021-12-13	MK1K	Patent expired